FinTechFunding

Amplia Therapeutics: Granted $2.1 million R&D cash flow loan

Amplia Therapeutics Granted $2.1 million R&D cash flow loan

  • Amplia Therapeutics (ATX) has been granted a $2.1 million Research and Development (R&D) cash flow loan
  • The $2.1 million will be awarded in two tranches: $1.3m in December this year and $0.8 million in the quarter ending March 31, 2022
  • The company says it will use funds to increase work on its second Focal Adhesion Kinase (FAK) inhibitor, AMP886
  • This will allow Amplia to evaluate new therapeutic opportunities and prepare preclinical activates designed to support future clinical trials of AMP886
  • AmpliaTherapeutics is up 2.9 per cent, trading at 18 cents at 12:40 pm AEDT
Previous article
STP Investment Services: Acquires Tower Fund Services
Next article
Altech Chemicals: Raises $8.1m for battery coating plant
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Mastercard Launches BIN Sponsorship Programme for UK Fintechs

New initiative aims to support fintech innovation in the UK market.Highlights: Mastercard unveils BIN sponsorship programme for UK...
FinTech

UAE Central Bank Trials Palm Payments, Amazon Abandons Technology

UAE's innovative palm payment trials contrast with Amazon's decision to discontinue similar tech.Highlights: UAE Central Bank begins trials...
FinTech

Checkout.com Acquires Euro Stablecoin Issuer Blue for Expansion

The acquisition strengthens Checkout.com’s capabilities in the stablecoin market.Highlights: Checkout.com has acquired Blue, a euro stablecoin issuer.The acquisition...
FinTech

Ex-Revolut Staffers Secure $6M for Self-Custodial Money App

Former team members aim to reshape financial independence with new app.Highlights: Ex-Revolut staffers raise $6M in funding.New app...

Follow us

Daily fintech insights, global payment trends, and industry moves that matter. Because in finance, timing is everything.

Company

Other Sites

MedNextz.com

Latest News

Mastercard Launches BIN Sponsorship Programme for UK Fintechs

FinTech 0
New initiative aims to support fintech innovation in the...

UAE Central Bank Trials Palm Payments, Amazon Abandons Technology

FinTech 0
UAE's innovative palm payment trials contrast with Amazon's decision...

Checkout.com Acquires Euro Stablecoin Issuer Blue for Expansion

FinTech 0
The acquisition strengthens Checkout.com’s capabilities in the stablecoin market.Highlights:...

Popular News

Mastercard Launches BIN Sponsorship Programme for UK Fintechs

FinTech 0
New initiative aims to support fintech innovation in the...

UAE Central Bank Trials Palm Payments, Amazon Abandons Technology

FinTech 0
UAE's innovative palm payment trials contrast with Amazon's decision...

Checkout.com Acquires Euro Stablecoin Issuer Blue for Expansion

FinTech 0
The acquisition strengthens Checkout.com’s capabilities in the stablecoin market.Highlights:...

© 2026 FintechInshorts. All Rights Reserved.